These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 11037612)

  • 1. [Are the hemochromatosis (HFE) gene mutation and hepatitis C virus (HCV) infection risk factors for porphyria cutanea tarda?].
    Nagy Z; Kószó F; Pár A; Nagy A; Horányi M; Morvay M; Dobozy A; Mózsik G
    Orv Hetil; 2000 Sep; 141(37):2031-4. PubMed ID: 11037612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemochromatosis (HFE) and transferrin receptor-1 (TFRC1) genes in sporadic porphyria cutanea tarda (sPCT).
    Lamoril J; Andant C; Gouya L; Malonova E; Grandchamp B; Martásek P; Deybac JC; Puy H
    Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):33-41. PubMed ID: 11929045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemochromatosis (HFE) gene mutations and hepatitis C virus infection as risk factors for porphyria cutanea tarda in Hungarian patients.
    Nagy Z; Kószó F; Pár A; Emri G; Horkay I; Horányi M; Karádi O; Rumi G; Morvay M; Varga V; Dobozy A; Mózsik G
    Liver Int; 2004 Feb; 24(1):16-20. PubMed ID: 15101996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Porphyria cutanea tarda in Brazilian patients: association with hemochromatosis C282Y mutation and hepatitis C virus infection.
    Martinelli AL; Zago MA; Roselino AM; Filho AB; Villanova MG; Secaf M; Tavella MH; Ramalho LN; Zucoloto S; Franco RF
    Am J Gastroenterol; 2000 Dec; 95(12):3516-21. PubMed ID: 11151887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance and prevalence of the C282Y gene mutation of primary hemochromatosis in the pathogenesis of pophyria cutanea tarda].
    Malina L; Zd'árský E; Dandová S; Michalíková H; Cerná M; Cimburová M
    Cas Lek Cesk; 2000 Nov; 139(23):728-30. PubMed ID: 11191743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The C282Y mutation in the haemochromatosis gene (HFE) and hepatitis C virus infection are independent cofactors for porphyria cutanea tarda in Australian patients.
    Stuart KA; Busfield F; Jazwinska EC; Gibson P; Butterworth LA; Cooksley WG; Powell LW; Crawford DH
    J Hepatol; 1998 Mar; 28(3):404-9. PubMed ID: 9551677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of the hemochromatosis gene in prophyria cutanea tarda. Prospective study of 56 cases].
    Skowron F; Bérard F; Grézard P; Wolf F; Morel Y; Perrot H
    Ann Dermatol Venereol; 2001 May; 128(5):600-4. PubMed ID: 11427792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America.
    Bonkovsky HL; Poh-Fitzpatrick M; Pimstone N; Obando J; Di Bisceglie A; Tattrie C; Tortorelli K; LeClair P; Mercurio MG; Lambrecht RW
    Hepatology; 1998 Jun; 27(6):1661-9. PubMed ID: 9620340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Porphyria cutanea tarda: the etiological importance of mutations in the HFE gene and viral infection is population-dependent.
    Hift RJ; Corrigall AV; Hancock V; Kannemeyer J; Kirsch RE; Meissner PN
    Cell Mol Biol (Noisy-le-grand); 2002 Dec; 48(8):853-9. PubMed ID: 12699243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hepatitis C, hemochromatosis and porphyria cutanea tarda].
    Teubner A; Richter M; Schuppan D; Köstler E; Stölzel U
    Dtsch Med Wochenschr; 2006 Mar; 131(13):691-5. PubMed ID: 16555178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence of HFE C282Y gene mutation is increased in Spanish patients with porphyria cutanea tarda without hepatitis C virus infection.
    Toll A; Celis R; Ozalla MD; Bruguera M; Herrero C; Ercilla MG
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1201-6. PubMed ID: 17062032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HFE mutations and transferrin receptor polymorphism analysis in porphyria cutanea tarda: a prospective study of 36 cases from southern France.
    Dereure O; Aguilar-Martinez P; Bessis D; Perney P; Vallat C; Guillot B; Blanc F; Guilhou JJ
    Br J Dermatol; 2001 Mar; 144(3):533-9. PubMed ID: 11260010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Porphyria cutanea tarda and hepatitis C viral infection. A clinical and virologic study.
    Cribier B; Petiau P; Keller F; Schmitt C; Vetter D; Heid E; Grosshans E
    Arch Dermatol; 1995 Jul; 131(7):801-4. PubMed ID: 7611796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porphyria cutanea tarda, hepatitis C, uroporphyrinogen decarboxylase and mutations of HFE gene. A case-control study.
    Cribier B; Chiaverini C; Dali-Youcef N; Schmitt M; Grima M; Hirth C; Lacour JP; Chosidow O
    Dermatology; 2009; 218(1):15-21. PubMed ID: 19001803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Porphyria cutanea tarda, C282Y, H63D and S65C HFE gene mutations and hepatitis C infection: a study from southern France.
    Chiavérini C; Halimi G; Ouzan D; Halfon P; Ortonne JP; Lacour JP
    Dermatology; 2003; 206(3):212-6. PubMed ID: 12673077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemochromatosis gene mutations in chronic hepatitis C patients with and without liver siderosis.
    Negro F; Samii K; Rubbia-Brandt L; Quadri R; Male PJ; Zarski JP; Baud M; Giostra E; Beris P; Hadengue A
    J Med Virol; 2000 Jan; 60(1):21-7. PubMed ID: 10568758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precipitating factors of porphyria cutanea tarda in Brazil with emphasis on hemochromatosis gene (HFE) mutations. Study of 60 patients.
    Vieira FM; Nakhle MC; Abrantes-Lemos CP; Cançado EL; Reis VM
    An Bras Dermatol; 2013; 88(4):530-40. PubMed ID: 24068123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of hepatitis C virus in porphyria cutanea tarda hepatopathy].
    Quecedo L; Costa J; Enríquez de Salamanca R
    Med Clin (Barc); 1996 Mar; 106(9):321-4. PubMed ID: 8667696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of hepatitis C and G in sporadic and familial porphyria cutanea tarda.
    Lamoril J; Andant C; Bogard C; Puy H; Gouya L; Pawlotsky JM; Da Silva V; Soulé JC; Deybach JC; Nordmann Y
    Hepatology; 1998 Mar; 27(3):848-52. PubMed ID: 9500716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of HFE gene mutations in patients with porphyria cutanea tarda in the Czech Republic.
    Kratka K; Dostalikova-Cimburova M; Michalikova H; Stransky J; Vranova J; Horak J
    Br J Dermatol; 2008 Sep; 159(3):585-90. PubMed ID: 18565178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.